The Market Intelligence Leader for the Diagnostics, Healthcare, and Healthcare IT Industries

Arlington, Virginia
Joined June 2009
"#IVD is a $113BN market, up from $99BN in 2020." VIDEO: Exciting news from @KaloramaInfo's "The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 18th Edition (2025-2030). #ThoughtLeaders #mrx #diagnostics #healthcare #InVitroDiagnostics #Science #Medicine #MarketResearch
2
2
197
Kalorama Information retweeted
The global sepsis diagnostics market is dynamic, but without reliable data on end-user spending, R&D can feel like a gamble. Kalorama's report turns uncertainty into a strategic roadmap. #Sepsis #HAIs #MedicalDevices #Biomarkers #MarketForecasts #Healthcare #Diagnostics #mrx
2
1
47
Want to know where #IVD is heading and how to position for 2026 and beyond? Join tomorrow’s FREE Worldwide IVD Tests #webinar covering key market drivers, growth through 2030, and competitive insights across leading global suppliers. shorturl.at/6tT0S #diagnostics #mrx
1
37
Kalorama Information retweeted
Hear from Daniel Granderson, Editor at @KaloramaInfo, as he shares research insights on two of the industry’s hottest areas--#AtHomeTesting and #Sepsis. linkedin.com/pulse/sepsis-ga… #IVD #Diagnostics #MedicalDiagnostics #InfectiousDisease #PointOfCare #POCT #DecentralizedCare #mrx
2
2
54
Hear from Daniel Granderson, Editor at @KaloramaInfo, as he shares research insights on two of the industry’s hottest areas--#AtHomeTesting and #Sepsis. linkedin.com/pulse/sepsis-ga… #IVD #Diagnostics #MedicalDiagnostics #InfectiousDisease #PointOfCare #POCT #DecentralizedCare #mrx
2
2
54
Kalorama Information retweeted
WATCH NOW: @KaloramaInfo's webinar on "Global Trends & Growth Opportunities in the IVD Market 2025" youtu.be/7-lFoAx7bcM?si=bXuz… #IVD #webinar #InVitroDiagnostics #Diagnostics #Healthcare #Medical #StrategicBriefing #marketresearch #mrx
2
2
79
The global sepsis diagnostics market is dynamic, but without reliable data on end-user spending, R&D can feel like a gamble. Kalorama's report turns uncertainty into a strategic roadmap. #Sepsis #HAIs #MedicalDevices #Biomarkers #MarketForecasts #Healthcare #Diagnostics #mrx
2
1
47
Kalorama Information retweeted
Data is only as valuable as the decisions it enables. Our report, #Biomarkers in #Diagnostics, provides the strategic intelligence you need to make confident, data-driven decisions. hubs.la/Q03N9kJG0 #BiomarkerMarket #DiagnosticTrends #StrategicPlanning #Healthcare #mrx
2
2
50
Kalorama Information retweeted
Kalorama's "#Benchmarking for 2025: Understanding the IVD User Experience" explores how #IVD vendors can enhance #CustomerExperience to strengthen relationships & drive growth. Learn more: scienceandmedicinegroup.com/… #Diagnostics #Healthcare #MarketResearch #Invitrodiagnostics #mrx
2
2
65
Kalorama Information retweeted
20 years strong! @KaloramaInfo continues to lead in IVD market insights. Where is #IVD in 2025—and where is it headed by 2030? "Worldwide Market for In Vitro Diagnostic Tests, 18th Edition" has the answers. scienceandmedicinegroup.com/… #Diagnostics #Healthcare #InVitroDiagnostics
2
2
52
Kalorama Information retweeted
Companion diagnostics is on track for double-digit growth through 2029 but success requires a strategic roadmap. @KaloramaInfo is here to help scienceandmedicinegroup.com/… #CompanionDiagnostics #CDx #PrecisionMedicine #NGS #MarketAnalysis #Biotech #Pharma #Healthcare #marketresearch
2
2
46
Companion diagnostics is on track for double-digit growth through 2029 but success requires a strategic roadmap. @KaloramaInfo is here to help scienceandmedicinegroup.com/… #CompanionDiagnostics #CDx #PrecisionMedicine #NGS #MarketAnalysis #Biotech #Pharma #Healthcare #marketresearch
2
2
46
Kalorama Information retweeted
New @SciSignal findings show that cells called leukocytes have a surface “coating” that can be modified during inflammatory conditions, such as #psoriasis, revealing how immune cells are recruited to sites of inflammation. scim.ag/43fjlDV
5
15
2
72
24,104
20 years strong! @KaloramaInfo continues to lead in IVD market insights. Where is #IVD in 2025—and where is it headed by 2030? "Worldwide Market for In Vitro Diagnostic Tests, 18th Edition" has the answers. scienceandmedicinegroup.com/… #Diagnostics #Healthcare #InVitroDiagnostics
2
2
52
Kalorama's "#Benchmarking for 2025: Understanding the IVD User Experience" explores how #IVD vendors can enhance #CustomerExperience to strengthen relationships & drive growth. Learn more: scienceandmedicinegroup.com/… #Diagnostics #Healthcare #MarketResearch #Invitrodiagnostics #mrx
2
2
65
Data is only as valuable as the decisions it enables. Our report, #Biomarkers in #Diagnostics, provides the strategic intelligence you need to make confident, data-driven decisions. hubs.la/Q03N9kJG0 #BiomarkerMarket #DiagnosticTrends #StrategicPlanning #Healthcare #mrx
2
2
50
Kalorama Information retweeted
What’s trending in the #IVD biomarker industry? Watch the latest video from @KaloramaInfo for key insights, and explore our full report: "#Biomarkers in #Diagnostics: Global Strategic Insights & Forecasts" scienceandmedicinegroup.com/… #invitrodiagnostics #healthcare #mrx #medical
2
2
56
What’s trending in the #IVD biomarker industry? Watch the latest video from @KaloramaInfo for key insights, and explore our full report: "#Biomarkers in #Diagnostics: Global Strategic Insights & Forecasts" scienceandmedicinegroup.com/… #invitrodiagnostics #healthcare #mrx #medical
2
2
56
Kalorama Information retweeted
What’s next for diagnostics? 🔬 Our new research highlights the biggest challenges, emerging technologies, and opportunities to improve patient outcomes over the next 5 years. 📖 Read the full study: is.gd/j8iAkw #Diagnostics #HealthcareInnovation #LifeSciences #DiagnosticsWorld #Immunodiagnostics
3
5
160
Kalorama Information retweeted
Today @WHO released its latest reports on #antibacterial agents in clinical and preclinical development, and on #diagnostics that are already available or in the pipeline to detect and identify priority #bacteria listed in the WHO bacterial priority pathogens list (BPPL). t.ly/XPRBL This is an opportunity to remind all stakeholders to work together to address the pipeline and access crisis for #antibiotics and #diagnostics t.ly/XOCPw
6
3
10
801